ArticleClinical and experimental nephrology2026
Low-dose exposure to organophosphate pesticides and chronic kidney disease: insights from urinary dialkyl phosphate biomarkers.
Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOrganophosphorus pesticide (OPP) exposure is a public health concern, yet the link between chronic low-level exposure and chronic kidney disease (CKD) in the general population remains unclear.
methodsThis study investigated the association between urinary dialkyl phosphate (DAP) metabolites and CKD prevalence among U.S. adults. Data from 5751 participants aged ≥ 20 years across five NHANES cycles (2003-2008, 2011-2016) were analyzed. Urinary DAP metabolites served as biomarkers of recent OPP or environmental DAP exposure. CKD associations were assessed using survey-weighted regression models. Secondary mixture analyses, including weighted quantile sum (WQS), Bayesian kernel machine regression (BKMR), and quantile g-computation (QGC), were conducted on metabolites with adequate detection frequency.
resultsOverall, 18.7% of participants met CKD criteria. Higher concentrations of diethylphosphate (DEP) and diethylthiophosphate (DETP) were consistently associated with increased CKD prevalence across models. Mixture analyses identified DEP and DETP as primary contributors to the overall association.
conclusionThis cross-sectional study indicates a potential link between exposure to specific DAPs (DEP and DETP) and an increased risk of CKD, supported by multiple statistical models. Longitudinal research to establish causality and clinical screening for OPPs exposure in unexplained CKD cases is warranted.
Indexed as
Identifiers
41961221What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.